Guide to Cystatin C

WRITTEN BY
Updated: 05/22/2025|12 min read

Summary

Cystatin C is a protein that provides a more accurate measure of kidney function than traditional tests because it's produced consistently by all cells and filtered almost entirely by the kidneys, making it independent of factors like muscle mass that can affect other kidney markers.

Why It Matters

Cystatin C is one of the most reliable markers for kidney function. Nearly all cells in the body produce it at a constant rate, and the kidneys almost completely filter it. In contrast, creatinine—another common marker of kidney function—is produced by muscle metabolism and is only partially filtered by the kidneys.

Because of its small size and positive charge, Cystatin C passes easily through the kidney's filtration barrier and is then almost entirely reabsorbed and broken down by tubular cells, with virtually none being secreted back into the blood. This makes it an important marker for estimating glomerular filtration rate (GFR)—the kidney's crucial filtering capacity that removes waste while retaining essential proteins and cells. When kidney filtration declines, Cystatin C accumulates in the blood, providing an accurate indicator of kidney function across different populations. eGFR can also be calculated using creatinine, and evidence suggests the two estimates together provide a more accurate picture than either one alone.

Cystatin C's particular value is its independence from muscle mass, which can significantly confound creatinine measurements. This makes it helpful in evaluating kidney function in elderly patients, those with unusual body compositions, malnutrition, chronic illness, or muscle wasting conditions. It can detect subtle changes in kidney function earlier than creatinine, potentially allowing for earlier intervention in kidney disease.

Cystatin C is also gaining recognition for its role in predicting cardiovascular risk, cognitive decline, and overall mortality risk, independent of its relationship to kidney function. Research suggests it may be an important marker of biological aging and systemic inflammation, making it valuable beyond just kidney assessment.

eGFR Correlation

Doctors estimate kidney function through eGFR calculations, and the most reliable equations use Cystatin C as a variable. More than 70 equations have been developed, with many variations and modifications for special populations. eGFR calculations have evolved from simple creatinine-based formulas to a more nuanced approach using multiple biomarkers. A normal eGFR is usually above 90 for most people. The lower the number gets, the less efficiently your kidneys are filtering. It's best to talk to a medical professional to understand how to use your Cystatin C number to calculate eGFR and approximate kidney function.

Associated Symptoms

Cystatin C levels themselves are laboratory findings rather than medical conditions. However, abnormal levels may be associated with various health conditions, each with their own symptoms.

Common symptoms that may indicate conditions associated with elevated Cystatin C (declining kidney function):

  • Fluid retention: Swelling in the legs, ankles, feet, or hands, which may be related to the kidneys' decreased ability to maintain fluid balance
  • Fatigue: Persistent tiredness and low energy, which could be associated with buildup of waste products and metabolic imbalances
  • Changes in urination: Decreased volume, increased frequency, or changes in color/appearance, which may reflect altered kidney filtration
  • High blood pressure: May develop or worsen with declining kidney function due to fluid retention and hormonal changes
  • Shortness of breath: Can occur with fluid buildup in the lungs when kidneys can't remove excess fluid effectively
  • Poor appetite: Nausea or decreased desire to eat, which may be related to waste product accumulation
  • Sleep disturbances: Difficulty sleeping or restless sleep, which could be related to metabolic imbalances
  • Cognitive changes: Difficulty concentrating or mental fogginess, which can be associated with waste product effects on brain function

Common symptoms that may indicate conditions causing temporary Cystatin C elevation:

  • Fever and inflammatory symptoms: Body aches, redness, or heat in affected areas during acute inflammation, which can temporarily raise Cystatin C
  • Thyroid symptoms: Depending on the direction of thyroid dysfunction, symptoms might include heat/cold intolerance, weight changes, or altered energy levels
  • Medication side effects: Various symptoms depending on the specific medication affecting Cystatin C levels

It's important to understand that many factors can cause these symptoms, and Cystatin C levels are just one piece of diagnostic information. The presence of symptoms alongside abnormal Cystatin C provides context for further investigation, but additional testing is typically needed to determine the underlying cause of kidney dysfunction. Many people with early kidney function decline and elevated Cystatin C may not experience any noticeable symptoms, which is why laboratory testing is particularly valuable for early detection.

Clinical Ranges

Female:

  • 19-29 Years: 0.52-1.28 mg/L
  • 30-39 Years: 0.52-1.24 mg/L
  • 40-49 Years: 0.52-1.21 mg/L
  • 50-59 Years: 0.52-1.17 mg/L
  • 60-69 Years: 0.52-1.14 mg/L
  • 70-79 Years: 0.52-1.10 mg/L
  • 80-89 Years: 0.52-1.07 mg/L
  • ≥90: Not established

Male:

  • 19-29 Years: 0.52-1.35 mg/L
  • 30-39 Years: 0.52-1.31 mg/L
  • 40-49 Years: 0.52-1.27 mg/L
  • 50-59 Years: 0.52-1.23 mg/L
  • 60-69 Years: 0.52-1.20 mg/L
  • 70-79 Years: 0.52-1.16 mg/L
  • 80-89 Years: 0.52-1.13 mg/L
  • ≥90: Not established

Special Considerations

  • Age: May increase with age
  • Pregnancy: May be slightly elevated
  • Thyroid dysfunction can affect levels
  • Inflammation can cause temporary elevation
  • Some medications may affect levels.

Lifestyle Factors That Can Impact It

Factors that can support healthy Cystatin C levels include:

  • Regular aerobic exercise improves kidney blood flow while reducing inflammation and supporting overall metabolic health that protects kidney function.
  • Maintaining healthy blood pressure reduces strain on the kidney's filtration system, prevents damage to small blood vessels, and helps maintain consistent filtration rates.
  • Adequate hydration supports optimal kidney filtration, prevents the concentration of waste products, and helps maintain proper blood volume.
  • A Mediterranean-style diet provides anti-inflammatory compounds and kidney-protective nutrients while supporting healthy blood pressure through lower sodium content.
  • A regular sleep schedule maintains the kidney's natural circadian rhythm and supports overall metabolic function.
  • Mind-body practices like yoga may support blood pressure control and reduce overall stress on the kidney system.

Factors that can have an adverse effect on levels include:

  • Smoking damages blood vessels including those in the kidneys while increasing inflammation and raising blood pressure, ultimately accelerating kidney aging.
  • Excessive alcohol consumption dehydrates the body and raises blood pressure while increasing inflammation.
  • Over-the-counter pain medications (NSAIDs) taken regularly can directly damage kidney tissue and impair filtration function.
  • Excessive protein supplementation or very high-protein diets can overwhelm the kidney's filtration capacity and lead to long-term strain.
  • Crash dieting or rapid weight loss may release toxins stored in fat tissue that must be filtered by the kidneys while potentially causing electrolyte imbalances.

Other Factors That Can Impact It

Medical Conditions

  • Thyroid dysfunction: Can significantly affect levels
  • Inflammation: May increase levels
  • Cancer: Can elevate levels
  • Diabetes: May affect progression
  • Cardiovascular disease: May correlate with elevated levels
  • Obesity: May influence levels indirectly
  • Autoimmune conditions: Can affect levels through inflammation

Medications

  • Corticosteroids: Can increase levels
  • Some HIV medications: May affect levels
  • Certain chemotherapy drugs: Can impact kidney function and levels
  • Anti-inflammatory medications: May influence levels
  • Nephrotoxic medications: Can affect levels through kidney impact

Other Factors

  • Age: Levels may increase with age
  • Pregnancy: Can affect levels
  • Genetics: Some genetic variants influence baseline levels
  • Body composition: May have less of an impact than on creatinine, but can still be relevant
  • Time of day: Shows minimal variation from night to day

How it Relates to Other Markers

Cystatin C vs Creatinine:

  • More sensitive to early kidney function decline
  • Less affected by diet, exercise, or muscle mass
  • Better predictor in elderly populations
  • More expensive but more accurate

Cystatin C with eGFR:

  • Combined Cystatin C and creatinine eGFR equations provide the most accurate kidney function estimates
  • Cystatin C-based eGFR particularly useful when creatinine-based estimates are unreliable

Relationship with Other Markers:

  • BUN (Blood Urea Nitrogen): Complementary marker for kidney function
  • Albumin/Creatinine Ratio: Can indicate kidney damage rather than function
  • Inflammatory markers: May correlate due to shared pathways

Testing Reliability and Variability

Timing And Collection

  • More stable than creatinine throughout the day with minimal night-to-day variation
  • Fasting status has minimal impact on results

Biological Variability

  • Much less variable than creatinine between individuals
  • Not significantly affected by muscle mass or body composition
  • May naturally increase with aging
  • May slightly vary during pregnancy

Factors That May Cause Unreliable Results

  • Severe acute inflammation can temporarily elevate levels
  • Uncontrolled thyroid conditions can affect results
  • Recent corticosteroid use may increase levels
  • Severe obesity may slightly impact results
  • Some forms of cancer can affect levels independently of kidney function
  • Acute illness can cause temporary elevation

Follow-Up Considerations

You should always talk to your doctor if you have medical concerns or questions.

When Re-Testing May be Appropriate

  • Normal results: Annual screening for at-risk populations
  • Borderline results: Repeat in 3-6 months
  • Elevated results: Repeat in 1-3 months
  • Significantly elevated: May require immediate medical attention

Additional Testing or Monitoring Your Doctor May Consider

  • Regular monitoring for those with kidney disease
  • More frequent monitoring during medication changes
  • Combined testing with creatinine for comprehensive assessment
  • Regular monitoring in elderly patients
  • Increased frequency with diabetes or hypertension

When Additional Care May be Warranted

  • Sustained elevation above reference range
  • Rapid increase in levels
  • Multiple abnormal kidney markers
  • Presence of symptoms (edema, fatigue, changes in urination)
  • High cardiovascular risk profile

Further Reading

The 2024 Levels Guide to kidneys and metabolic health

Bibliography

References

1. Inker, Lesley A., et al. "KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD." American Journal of Kidney Diseases, vol. 63, no. 5, 2014, pp. 713-735. https://doi.org/10.1053/j.ajkd.2014.01.416.​

2. Shlipak, Michael G., et al. "Cystatin C versus Creatinine in Determining Risk Based on Kidney Function." New England Journal of Medicine, vol. 369, no. 10, 2013, pp. 932-943. https://doi.org/10.1056/NEJMoa1214234.​

3. Angelidis, Christos, et al. "Cystatin C: An Emerging Biomarker in Cardiovascular Disease." Current Topics in Medicinal Chemistry, vol. 13, no.

4. Svensson-Färbom, Pia, et al. "Cystatin C Identifies Cardiovascular Risk Better Than Creatinine-Based Estimates of Glomerular Filtration in Middle-Aged Individuals Without a History of Cardiovascular Disease." Journal of Internal Medicine, vol. 275, no. 5, 2014, pp. 506-521. https://doi.org/10.1111/joim.12169

5. Luo, Jing, et al. "Cystatin C and Cardiovascular or All-Cause Mortality Risk in the General Population: A Meta-Analysis." Clinica Chimica Acta, vol. 450, 2015, pp. 39-45. https://doi.org/10.1016/j.cca.2015.07.016

6. Melsom, Toralf, et al. "Estimated GFR Is Biased by Non-Traditional Cardiovascular Risk Factors." American Journal of Nephrology, vol. 41, no. 1, 2015, pp. 7-15. http://dx.doi.org/10.1159/000371557.

7. Rule, Andrew D., et al. "GFR Estimating Equations: Getting Closer to the Truth?" Clinical Journal of the American Society of Nephrology, vol. 8, no. 8, 2013, pp. 1414-1420. http://dx.doi.org/10.2215/CJN.01240213.​

8. Tangri, Navdeep, et al. "Risk Prediction Models for Patients with Chronic Kidney Disease: A Systematic Review." Annals of Internal Medicine, vol. 158, no. 8, 2013, pp. 596-603. https://doi.org/10.7326/0003-4819-158-8-201304160-00004.​

9. Levey, Andrew S., et al. "GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration." American Journal of Kidney Diseases, vol. 64, no. 6, 2014, pp. 821-835. https://doi.org/10.1053/j.ajkd.2014.07.030.​

10. Newman, D. J. "Cystatin C." Annals of Clinical Biochemistry, vol. 39, no. 2, 2002, pp. 89-104. https://doi.org/10.1258/0004563021901847.​

11. Foster, Meredith C., et al. "Novel Filtration Markers as Predictors of All-Cause and Cardiovascular Mortality in US Adults." American Journal of Kidney Diseases, vol. 62, no. 1, 2013, pp. 42-51. http://dx.doi.org/10.1053/j.ajkd.2013.01.016.

12. Peralta, Carmen A., et al. "Detection of Chronic Kidney Disease with Creatinine, Cystatin C, and Urine Albumin-to-Creatinine Ratio and Association with Progression to End-Stage Renal Disease and Mortality." JAMA, vol. 305, no. 15, 2011, pp. 1545-1552. https://doi.org/10.1001/jama.2011.468.​

13. Levey, Andrew S., et al. "A New Equation to Estimate Glomerular Filtration Rate." Annals of Internal Medicine, vol. 150, no. 9, 2009, pp. 604-612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006.

14. Inker, Lesley A., et al. "New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race." New England Journal of Medicine, vol. 385, no. 19, 2021, pp. 1737-1749. http://dx.doi.org/10.1056/NEJMoa2102953

15. Levey, Andrew S., et al. "Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate." Annals of Internal Medicine, vol. 145, no. 4, 2006, pp. 247-254. https://doi.org/10.7326/0003-4819-145-4-200608150-00004.​

16. Inker, Lesley A., et al. "Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C." New England Journal of Medicine, vol. 367, no. 1, 2012, pp. 20-29. https://doi.org/10.1056/NEJMoa1114248.​

17. Pottel, Hans, et al. "An Estimated Glomerular Filtration Rate Equation for the Full Age Spectrum." Nephrology Dialysis Transplantation, vol. 31, no. 5, 2016, pp. 798-806. https://doi.org/10.1093/ndt/gfv454

18. "KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease." Kidney International Supplements, vol. 3, no. 1, 2013, pp. 1-150. https://doi.org/10.1038/kisup.2012.73.​

19. National Kidney Foundation. "K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification." American Journal of Kidney Diseases, vol. 39, no. 2 Suppl 1, 2002, pp. S1-266.https://pubmed.ncbi.nlm.nih.gov/11904577/

Sign up for the Levels Newsletter